TARCEVA (Avera McKennan Hospital)
Welcome to the PulseAid listing for the TARCEVA drug offered from Avera McKennan Hospital. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
| NON-PROPRIETARY NAME: | erlotinib hydrochloride |
| SUBSTANCE NAME: | ERLOTINIB HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-04-01 |
| END MARKETING DATE: | 0000-00-00 |
TARCEVA HUMAN PRESCRIPTION DRUG Details:
| Item Description | TARCEVA from Avera McKennan Hospital |
| LABELER NAME: | Avera McKennan Hospital |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2015-04-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69189-0063_0ecb4ca6-ccf8-4945-ac60-88acc36d8003 |
| PRODUCT NDC: | 69189-0063 |
| APPLICATION NUMBER: | NDA021743 |
Other ERLOTINIB HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
